Finlayson Emily V A, Birkmeyer John D, Stukel Therese A, Siewers Andrea E, Lucas F Lee, Wennberg David E
VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, VT 05009, USA.
Surgery. 2002 Nov;132(5):787-94. doi: 10.1067/msy.2002.126509.
Background. Studies of medical admissions have questioned the validity of using claims data to adjust for preexisting medical conditions (comorbidities), but the impact of using comorbidities from claims data to risk-adjust mortality rates for high-risk surgery is not well characterized. The purpose of this study was to evaluate the relationship between comorbidities and mortality in administrative data in surgical populations and identify better risk-adjustment methods. Methods. Using the national Medicare database (1994-1997), we identified admissions for elective abdominal aortic aneurysm repair (140,577) and pancreaticoduodenectomy (10,530). We calculated the relative risk of mortality (adjusted for age, sex, race, and admission acuity) for 5 chronic conditions that are known (from clinical series) to increase the risk of postoperative mortality and are commonly used in claims-based risk-adjustment models. To explore the potential value of alternative risk-adjustment strategies, we examined relationships between surgical mortality and comorbidities using diagnosis codes identified from previous admissions. Results. Overall, in-hospital mortality for elective abdominal aortic aneurysm (AAA) repair and pancreaticoduodenectomy were 5.1% and 10.4%, respectively. For both procedures, 3 of the 5 comorbidities were associated with decreased risk of mortality: prior myocardial infarction (MI) [RR = 0.38; 95% confidence interval (CI), 0.33-0.43 for AAA; RR = 0.38; 95% CI, 0.21-0.69 for pancreaticoduodenectomy), malignancy (RR = 0.67; 95% CI, 0.59-0.76 for AAA; RR = 0.74; 95% CI, 0.45-1.21 for pancreaticoduodenectomy], and diabetes (RR = 0.76; 95% CI, 0.64-0.84 for AAA; RR = 0.59; 95% CI, 0.49-0.69 for pancreaticoduodenectomy). Using comorbidities identified from prior admissions increased the mortality risk estimates for prior MI (RR = 1.22; 95% CI, 1.08-1.38 for AAA; RR = 0.80; 95% CI, 0.49-1.30 for pancreaticoduodenectomy) and diabetes (RR = 1.41; 95% CI, 1.25-1.59 for AAA; RR = 0.94; 95% CI, 0.78-1.14 for pancreaticoduodenectomy). Conclusions. Because comorbidities coded on the index admission appear protective, incorporating them in risk-adjustment models for studies comparing surgical performance may penalize providers for taking care of sicker patients. When available, comorbidity information from prior hospitalizations may be more useful for risk adjustment.
背景。关于医疗入院情况的研究对使用索赔数据来调整既往存在的医疗状况(合并症)的有效性提出了质疑,但使用索赔数据中的合并症对高风险手术的死亡率进行风险调整的影响尚未得到充分描述。本研究的目的是评估手术人群管理数据中合并症与死亡率之间的关系,并确定更好的风险调整方法。方法。利用国家医疗保险数据库(1994 - 1997年),我们确定了择期腹主动脉瘤修复术(140,577例)和胰十二指肠切除术(10,530例)的入院病例。我们计算了5种慢性病(从临床系列研究可知)的死亡相对风险(根据年龄、性别、种族和入院急症程度进行调整),这些慢性病会增加术后死亡风险,并且常用于基于索赔的风险调整模型。为了探索替代风险调整策略的潜在价值,我们使用先前入院记录中确定的诊断代码检查了手术死亡率与合并症之间的关系。结果。总体而言,择期腹主动脉瘤(AAA)修复术和胰十二指肠切除术的住院死亡率分别为5.1%和10.4%。对于这两种手术,5种合并症中有3种与死亡风险降低相关:既往心肌梗死(MI)[AAA的RR = 0.38;95%置信区间(CI),0.33 - 0.43;胰十二指肠切除术的RR = 0.38;95% CI,0.21 - 0.69]、恶性肿瘤(AAA的RR = 0.67;95% CI,0.59 - 0.76;胰十二指肠切除术的RR = 0.74;95% CI,0.45 - 1.21)和糖尿病(AAA的RR = 0.76;95% CI,0.64 - 0.84;胰十二指肠切除术的RR = 0.59;95% CI,0.49 - 0.69)。使用先前入院记录中确定的合并症会增加既往MI(AAA的RR = 1.22;95% CI,1.08 - 1.38;胰十二指肠切除术的RR = 0.80;95% CI,0.49 - 1.30)和糖尿病(AAA的RR = 1.41;95% CI,1.25 - 1.59;胰十二指肠切除术的RR = 0.94;95% CI,0.78 - 1.14)的死亡风险估计值。结论。由于索引入院时编码的合并症似乎具有保护作用,将其纳入用于比较手术表现的研究的风险调整模型中可能会使照顾病情较重患者的医疗服务提供者受到惩罚。如有可用信息,来自先前住院的合并症信息可能对风险调整更有用。